DIOVAN
Pronunciation: val-SAR-tan (DYE-oe-van)


What it isAngiotensin II receptor blocker; hypertension, heart failure and post-infarction.
Why this oneHeart-failure outcome data, no cough, and it is the ARB component of sacubitril-valsartan.
What limits itHyperkalemia and the same hemodynamic creatinine rise as an ACE inhibitor. Contraindicated in pregnancy.
Animated chart of estimated U.S. prescriptions per year, RAAS inhibitors (1981–2026). Valsartan enters in 1997 (estimated).
Principal riskHyperkalemia and acute kidney injury
Legacy pregnancy categoryD
Defining liabilityHyperkalemia, kidney injury, fetal toxicity and increased lithium exposure.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Hypertension | Adults | 80–160 mg QD | 80–320 mg QD | 320 mg QD |
| Hypertension | Peds 1–16 y | 1 mg/kg QD (up to 40 mg) | 1–4 mg/kg QD (up to 160 mg) | 160 mg QD |
| Heart failure | Adults | 40 mg BID | 40–160 mg BID | 160 mg BID |
| Post-myocardial infarction | Adults | 20 mg BID | 20–160 mg BID | 160 mg BID |
Renal Undefined
Hepatic Undefined
Available strengths
Pregnancy Can cause fetal harm; discontinue as soon as pregnancy is detected.
Lactation Breastfeeding is not recommended.
| Strength | #/mo | generic $/mo | CostPlus | |
|---|---|---|---|---|
| 40 mg | tab | 30 qd | $2.89 | offered |
| 80 mg | tab | 30 qd | $2.46 | offered |
| 160 mg | tab | 30 qd | $3.18 | offered |
| 320 mg | tab | 30 qd | $4.90 | offered |
Available combined with: Sacubitril (in ENTRESTO) · sacubitril / valsartan
Generic entry2014
Open Valsartan in the interactive console ↗

Open Valsartan in the interactive console ↗